Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,706.00
Bid: 2,690.00
Ask: 2,692.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.074%)
Open: 2,704.00
High: 2,710.00
Low: 2,680.00
Prev. Close: 2,706.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Composition of the Committees of the BoD

16 Jun 2020 13:42

RNS Number : 1379Q
Coca-Cola HBC AG
16 June 2020
 

 

Coca-Cola HBC AGComposition of the Committees of the Board of Directors of Coca-Cola HBC AG

 

 

Zug, Switzerland - 16 June 2020 - Coca-Cola HBC AG ("Coca-Cola HBC" or the "Company") announces today that its board of directors (the "Board") has re-appointed all members of the Board Committees.

 

The composition of the Board Committees will be as follows:

Audit and Risk Committee

Bill  Douglas  (Chair)

Olusola David-Borha

Alexandra Papalexopoulou

Nomination Committee

Reto Francioni (Chair)

Charlotte Boyle

Anna Diamantopoulou

Remuneration Committee

Charlotte J. Boyle (Chair)

Reto Francioni

Anna Diamantopoulou

Social Responsibility Committee

 Anastasios  I. Leventis (Chair)

 Anna Diamantopoulou

José Octavio Reyes

This announcement is made pursuant to the Financial Conduct Authority's Listing Rule 9.6.11.

 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

Media:

David Hart

Group Communication Director

Tel: +41 41 726 0143

 david.hart@cchellenic.com

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with 2019 revenue in excess of €7 billion. It has a broad geographic footprint with operations in 28 countries serving a population of more than 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, plant based beverages and ready-to-drink tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good, among others.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBDGDLRXBDGGL
Date   Source Headline
6th Mar 20193:17 pmRNSDirector/PDMR Shareholding
6th Mar 20197:00 amRNSTransaction in Own Shares
5th Mar 20197:00 amRNSTransaction in Own Shares
4th Mar 20197:04 amRNSTransaction in Own Shares
1st Mar 201911:08 amRNSIssue of equity and total voting rights
1st Mar 20197:02 amRNSTransaction in Own Shares
28th Feb 20197:10 amRNSTransaction in Own Shares
27th Feb 201911:00 amRNSDirector/PDMR Shareholding
27th Feb 20197:02 amRNSTransaction in Own Shares
26th Feb 20197:07 amRNSTransaction in Own Shares
25th Feb 20197:02 amRNSTransaction in Own Shares
22nd Feb 20197:05 amRNSTransaction in Own Shares
21st Feb 20197:00 amRNSTransaction in Own Shares
20th Feb 20197:00 amRNSTransaction in Own Shares
19th Feb 201911:12 amRNSDirector/PDMR Shareholding
19th Feb 20197:00 amRNSTransaction in Own Shares
18th Feb 201912:06 pmRNSDirector/PDMR Shareholding
18th Feb 20197:15 amRNSTransaction in Own Shares
18th Feb 20197:00 amRNSAcquires Serbia's leading confectionery brand
15th Feb 20197:05 amRNSTransaction in Own Shares
14th Feb 20197:00 amRNSSTRONG REVENUE GROWTH DRIVES MARGIN EXPANSION
4th Feb 20197:11 amRNSTransaction in Own Shares
1st Feb 20197:00 amRNSTransaction in Own Shares
31st Jan 20197:00 amRNSTransaction in Own Shares
30th Jan 20197:00 amRNSTransaction in Own Shares
29th Jan 20197:00 amRNSTransaction in Own Shares
28th Jan 20197:01 amRNSTransaction in Own Shares
25th Jan 20197:05 amRNSTransaction in Own Shares
24th Jan 20197:00 amRNSTransaction in Own Shares
23rd Jan 20197:05 amRNSTransaction in Own Shares
22nd Jan 20197:00 amRNSTransaction in Own Shares
21st Jan 20197:12 amRNSTransaction in Own Shares
18th Jan 20191:43 pmRNSDirector/PDMR Shareholding
18th Jan 20197:05 amRNSTransaction in Own Shares
17th Jan 20197:11 amRNSTransaction in Own Shares
16th Jan 20197:16 amRNSTransaction in Own Shares
15th Jan 20197:03 amRNSTransaction in Own Shares
14th Jan 20192:26 pmRNSNotice of Results
14th Jan 20197:09 amRNSTransaction in Own Shares
11th Jan 20197:21 amRNSTransaction in Own Shares
10th Jan 20197:13 amRNSTransaction in Own Shares
7th Jan 20192:18 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 20199:35 amRNSIssue of equity and total voting rights
18th Dec 20181:58 pmRNSDirector/PDMR Shareholding
17th Dec 20187:27 amRNSTransaction in Own Shares
14th Dec 20187:14 amRNSTransaction in Own Shares
13th Dec 201811:37 amRNSHolding(s) in Company
13th Dec 20187:16 amRNSTransaction in Own Shares
12th Dec 20187:13 amRNSTransaction in Own Shares
11th Dec 20187:11 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.